ISPC
NASDAQiSpecimen Inc.
News · 26 weeks36+100%
2025-12-072026-05-31
Mix1690d
- SEC Filings10(63%)
- Other6(38%)
Latest news
25 items- SECiSpecimen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - iSpecimen Inc. (0001558569) (Filer)
- SECSEC Form DEFA14A filed by iSpecimen Inc.DEFA14A - iSpecimen Inc. (0001558569) (Filer)
- SECSEC Form D filed by iSpecimen Inc.D - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - iSpecimen Inc. (0001558569) (Filer)
- PRE.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private PlacementNEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers. This transaction represents E.F. Hutton's latest financing completed with iSpecimen. In December 2025, E.F. Hutton also acted as the exclusive placement agent in connection with a separate private placement for
- PRiSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private PlacementMay 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the offering, the Company will issue 488,281 shares of common stock (the "Shares") at a purchase price of $5.12 per Share. In lieu of Shares that would otherwise result i
- SECiSpecimen Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Other Events8-K - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - iSpecimen Inc. (0001558569) (Filer)
- PRiSpecimen Achieves 85% Reduction in Human Biospecimen Shipping TimeWoburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ:ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and internationally.By reducing reliance on centralized hub processing, the new model simplifies logistics and eliminates multi-step routing. Previously, shipments often required routing through a central hub, which could add 7-14 days to transit times. Under the updated approach, domestic shipments can now be delivered in as little as 1-2 days, reducing transit times by approximately 70-85% while also lowering overall shippi
- SECSEC Form 10-K filed by iSpecimen Inc.10-K - iSpecimen Inc. (0001558569) (Filer)
- SECSEC Form NT 10-K filed by iSpecimen Inc.NT 10-K - iSpecimen Inc. (0001558569) (Filer)
- PRiSpecimen Achieves Rapid Procurement Milestone for Influenza ResearchWoburn, Massachusetts--(Newsfile Corp. - March 16, 2026) - iSpecimen Inc. (NASDAQ:ISPC) (the "Company"), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the responsiveness and capabilities of its site network. Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected approximately 500 influenza swab samples over a period of several weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnarou
- SECiSpecimen Inc. filed SEC Form 8-K: Other Events8-K - iSpecimen Inc. (0001558569) (Filer)
- PRiSpecimen Launches AI Agent Revolutionizing Biospecimen MatchingStrengthens iSpecimen's next-generation marketplace platform Woburn, MA, March 12, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (the "Company") (NASDAQ:ISPC), a leading technology marketplace connecting researchers with biospecimen suppliers, today announced the launch of its new AI-powered Inventory Agent, a purpose-built tool designed to help accelerate the process of reviewing incoming biospecimen requests and matching them with available inventory across its global supplier network. The internally developed AI agent analyzes incoming request criteria and is designed to identify potential biospecimen matches, enabling the iSpecimen team to respond to research inquiries with greater speed
- SECSEC Form DEFA14A filed by iSpecimen Inc.DEFA14A - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Leadership Update8-K - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Other Events8-K - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - iSpecimen Inc. (0001558569) (Filer)
- PRiSpecimen Announces Milestone 2: System Integration and Marketplace Activation CompleteLive Production Marketplace Now AvailableWoburn, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC) today announced the successful completion of Milestone 2, System Integration and Marketplace Activation, marking a pivotal step in the SalesStack digital transformation journey. The milestone delivers a fully integrated, live marketplace that connects customer requests with supplier inventories, enabling streamlined operations, reduced costs, and a foundation for future growth.Chief Executive Officer Ms. Katie Field commented, "This Milestone 2 achievement demonstrates end-to-end system integration, legacy data migration, and activation of a production-ready Sale
- PRiSpecimen Achieves Rapid Procurement Milestone for Influenza ResearchLexington, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the strength, responsiveness, and reliability of its site network.Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected 500 influenza swab samples in just a few weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnaround and quality of the speci
- SECSEC Form 424B3 filed by iSpecimen Inc.424B3 - iSpecimen Inc. (0001558569) (Filer)
- SECSEC Form EFFECT filed by iSpecimen Inc.EFFECT - iSpecimen Inc. (0001558569) (Filer)
- SECiSpecimen Inc. filed SEC Form 8-K: Other Events8-K - iSpecimen Inc. (0001558569) (Filer)
ISPC FAQ
6 questionsWhere does ISPC stock trade?
iSpecimen Inc. (ISPC) is listed on NASDAQ.What sector and industry is ISPC in?
iSpecimen Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did iSpecimen Inc. go public?
iSpecimen Inc. (ISPC) completed its IPO in 2021.What are analysts saying about ISPC?
iSpecimen Inc. has had 2 recent analyst actions on file. The most recent action was from Craig-Hallum: Buy with a $2000.00 price target on 2022-01-04. Recent price targets range from $1200.00 to $2000.00.What companies are similar to ISPC?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), PPD (PPD, Inc.), MEDP (Medpace Holdings Inc.), ICLR (ICON plc). Compare ISPC side-by-side with any of them on Quantisnow.How can I track ISPC on Quantisnow?
Quantisnow aggregates iSpecimen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISPC to receive live email and push alerts on every new disclosure.